F N B (NYSE:FNB) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.30 by 13.33 percent. This is a 30.77 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $321.30 million which beat the analyst consensus estimate of $307.02 million by 4.65 percent. This is a 4.61 percent increase over sales of $307.14 million the same period last year.
F N B Q3 EPS $0.34 Beats $0.30 Estimate, Sales $321.30M Beat $307.02M Estimate
F N B (NYSE:FNB) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.30 by 13.33 percent. This is a 30.77 percent increase over earnings of $0.26 per share from the same period
Related Posts
‘New Jersey Marijuana Sales Reach $24 Million In First Month Of Adult-Use Market Launch’ -Marijuana Moment
https://www.marijuanamoment.net/new-jersey-marijuana-sales-reach-24-million-in-first-month-of-adult-use-market-launch/
As Elon Musk Points To Japan ‘Adult Diaper’ Stats To Back His ‘Population Collapse’ Warning — Another Metric Worries Tokyo
Days after Tesla Inc (NASDAQ: TSLA) CEO Elon Musk reiterated his warning about the plummeting population of Earth and pointed to the ratio of "adult diapers" to "baby diapers" in Japan as a cause of concern, another metric is now worrying the country's capi
Bellerophon Therapeutics Announces License Agreement For The Commercialization Of INOpulse In Greater China With Baylor BioSciences
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today